DKK1‐CKAP4 signal axis promotes hepatocellular carcinoma aggressiveness
Open Access
- 9 March 2023
- journal article
- research article
- Published by Wiley in Cancer Science
- Vol. 114 (5) , 2063-2077
Abstract
Hepatocellular carcinoma (HCC) is the most prevalent malignant liver neoplasm. Despite the advances in diagnosis and treatment, the prognosis of HCC patients remains poor. Cytoskeleton‐associated membrane protein 4 (CKAP4) is a receptor of the glycosylated secretory protein Dickkopf‐1 (DKK1), and the DKK1‐CKAP4 axis is activated in pancreatic, lung, and esophageal cancer cells. Expression of DKK1 and CKAP4 has been examined in HCC in independent studies that yielded contradictory results. In this study, the relationship between the DKK1‐CKAP4 axis and HCC was comprehensively examined. In 412 HCC cases, patients whose tumors were positive for both DKK1 and CKAP4 had a poor prognosis compared to those who were positive for only one of these markers or negative for both. Deletion of either DKK1 or CKAP4 inhibited HCC cell growth. In contrast to WT DKK1, DKK1 lacking the CKAP4 binding region did not rescue the phenotypes caused by DKK1 depletion, suggesting that binding of DKK1 to CKAP4 is required for HCC cell proliferation. Anti‐CKAP4 Ab inhibited HCC growth, and its antitumor effect was clearly enhanced when combined with lenvatinib, a multikinase inhibitor. These results indicate that simultaneous expression of DKK1 and CKAP4 is involved in the aggressiveness of HCC, and that the combination of anti‐CKAP4 Ab and other therapeutics including lenvatinib could represent a promising strategy for treating advanced HCC.Keywords
This publication has 46 references indexed in Scilit:
- Dickkopf-1: As a Diagnostic and Prognostic Serum Marker for Early Hepatocellular CarcinomaThe International Journal of Biological Markers, 2013
- Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cellsMolecular Cancer, 2012
- Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic ReprogrammingCancer Cell, 2012
- Mechanisms Determining the Morphology of the Peripheral ERCell, 2010
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Proliferation and migration mediated by Dkk-1/Wnt/β-catenin cascade in a model of hepatocellular carcinoma cellsTranslational Research, 2007
- Function and biological roles of the Dickkopf family of Wnt modulatorsOncogene, 2006
- Morphogenesis of the Endoplasmic Reticulum: Beyond Active Membrane ExpansionTraffic, 2006
- Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapyBiochemical and Biophysical Research Communications, 2005
- A novel direct interaction of endoplasmic reticulum with microtubulesThe EMBO Journal, 1998